Biology and relevance of stem cells in squamous head and neck cancer: Latest insights and review of literature;Biologie und Bedeutung von Tumorstammzellen in der HNO: Neueste Erkenntnisse und Zusammenfassung der aktuellen Literatur

Laryngo- Rhino- Otologie

Volumn 91, Issue 5, 2012, Pages 326-335

  Oker, N ^a   Kaufmann, A M ^a   Albers, A E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ALDH1; cancer stem cells; chemoresistance; epithelial mesenchymal transition; head and neck squamous cell carcinoma; human Papillomavirus; immunotherapy; metastasis; radioresistance; stem cells; stemness related genes; symmetric and asymmetric cell division; therapeutic targetting of CSC

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; STEM CELL FACTOR;

CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STEM CELL; CELL RENEWAL; CHEMORADIOTHERAPY; EPITHELIAL MESENCHYMAL TRANSITION; HEAD AND NECK CANCER; HUMAN; IMMUNOGENICITY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; NEOPLASTIC STEM CELLS; OTORHINOLARYNGOLOGIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859820545     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0032-1306364     Document Type: Review

References (21)

1. Bonnet D, Dick J E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med: 1997; 3 730 737 (Pubitemid 27298715)
2. Wei Y, Li Y, Chen C et al. Human skeletal muscle-derived stem cells retain stem cell properties after expansion in myosphere culture. Exp Cell Res 317 1016 1027
3. Dick J E. Stem cell concepts renew cancer research. Blood: 2008; 112 4793 4807
4. Dalerba P, Cho R W, Clarke M F. Cancer stem cells: models and concepts. Annu Rev Med: 2007; 58 267 284 (Pubitemid 46706514)
5. Kennedy J A, Barabe F, Poeppl A G et al. Comment on "Tumor growth need not be driven by rare cancer stem cellso" Science: 2007; 318 1722 author reply 1722
6. Chen C, Wei Y, Hummel M et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PloS one: 2011; 6 e16466
7. Schatton T, Frank N Y, Frank M H. Identification and targeting of cancer stem cells. Bioessays: 2009; 31 1038 1049
8. Albers A E, Chen C, Koberle B et al. Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol: 2011; 81 224 240
9. Martens J E, Arends J, Van der Linden P J et al. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res: 2004; 24 771 775 (Pubitemid 38625020)
10. Chen Y C, Chen Y W, Hsu H S et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun: 2009; 385 307 313
11. Ginestier C, Hur M H, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell: 2007; 1 555 567 (Pubitemid 350056407)
12. Vered M, Dayan D, Yahalom R et al. Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer: 2010; 127 1356 1362
13. Kashyap V, Rezende N C, Scotland K B et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev: 2009; 18 1093 1108
14. Visus C, Ito D, Amoscato A et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res: 2007; 67 10538 10545 (Pubitemid 350070830)
15. Albers A E, Strauss L, Liao T et al. T cell-tumor interaction directs the development of immunotherapies in head and neck cancer. Clin Dev Immunol: 2010; 236378
16. Albers A E, Visus C, Tsukishiro T et al. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res: 2006; 12 2394 2403
17. Xu Q, Liu G, Yuan X et al. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells: 2009; 27 1734 1740
18. Chen Y C, Chang C J, Hsu H S et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol: 2009; 46 158 165
19. St John M A, Dohadwala M, Luo J et al. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res: 2009; 15 6018 6027
20. Smith L M, Nesterova A, Ryan M C et al. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer: 2008; 99 100 109 (Pubitemid 351920235)
21. Piccirillo S G, Reynolds B A, Zanetti N et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature: 2006; 444 761 765 (Pubitemid 44949605)